Ly-co Liquid
NDC Package 58048-0006-1
Package Information
Ly-co (angelica archangelica, kali muriaticum, yucca filamentosa, cartilago suis, phytolacca decandra, hydrastis canadensis, rhus tox, causticum, magnesia phosphorica, manganum metallicum, oxalicum acidum, arnica montana, borrelia burgdorferi nosode, latrodectus mactans, citricum acidum, cytomegalovirus nosode, rickettsia nosode (rickettsia prowazekii), chlamydia trachomatis, ledum palustre) liquids is take 10 drops 1 to 3 times per day under the tongue 30 minutes before meal or as directed by a Health Care Practitioner.Consult your physician for use in children under 12 years of age. This formulation utilizes a liquid delivery system. Marketed by Bhp Holdings, Inc., this product is identified by NDC 58048-0006.
Identification & Billing
Clinical Specifications
- ANGELICA ARCHANGELICA ROOT 2 [hp_X]/mL
- ANHYDROUS CITRIC ACID 6 [hp_C]/mL
- ARNICA MONTANA WHOLE 8 [hp_X]/mL
- BORRELIA BURGDORFERI 12 [hp_X]/mL
- CAUSTICUM 6 [hp_X]/mL
- CHLAMYDIA TRACHOMATIS 12 [hp_C]/mL
- GOLDENSEAL 5 [hp_X]/mL
- HUMAN HERPESVIRUS 5 6 [hp_C]/mL
- LATRODECTUS MACTANS 12 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 8 [hp_X]/mL
- MANGANESE 8 [hp_X]/mL
- OXALIC ACID DIHYDRATE 8 [hp_X]/mL
- PHYTOLACCA AMERICANA ROOT 4 [hp_X]/mL
- POTASSIUM CHLORIDE 3 [hp_X]/mL
- RHODODENDRON TOMENTOSUM LEAFY TWIG 30 [hp_C]/mL
- RICKETTSIA PROWAZEKII 8 [hp_C]/mL
- SUS SCROFA CARTILAGE 4 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/mL
- YUCCA FILAMENTOSA WHOLE 3 [hp_X]/mL
- Acidifying Activity - [MoA] (Mechanism of Action)
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 58048 - Bhp Holdings, Inc.
- 58048-0006 - Ly-co
- 58048-0006-1 - 60 mL in 1 BOTTLE, DROPPER
- 58048-0006 - Ly-co
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58048-0006-1 identifies a specific commercial package of 60 ml in 1 bottle, dropper of Ly-co, a human over the counter drug labeled by Bhp Holdings, Inc.. This liquid is formulated for oral use and contains angelica archangelica root; anhydrous citric acid; arnica montana whole; borrelia burgdorferi; causticum; chlamydia trachomatis; goldenseal; human herpesvirus 5; latrodectus mactans; magnesium phosphate, dibasic trihydrate; manganese; oxalic acid dihydrate; phytolacca americana root; potassium chloride; rhododendron tomentosum leafy twig; rickettsia prowazekii; sus scrofa cartilage; toxicodendron pubescens leaf; yucca filamentosa whole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bhp Holdings, Inc. on June 01, 2023. The current certification is valid through December 31, 2026.
How is this Bhp Holdings, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58048000601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.